Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenues
Operating Expenses:        
Research and development (including $0 and $201 expense from stock compensation granted to officers, directors and employees during the three months ended September 30, 2023 and 2022, and $13 and $327 for the nine months ended September 30, 2023 and 2022, respectively) 1,364 2,743 5,109 5,969
Selling, general and administrative (including $0.5 million and $2.7 million expense from stock compensation granted to officers, directors and employees during the three months ended September 30, 2023 and 2022, respectively and $1.8 million and $3.5 million for the nine months ended September 30, 2023 and 2022, respectively) 1,758 4,280 5,299 9,510
Loss from Operations 3,122 7,023 10,408 15,479
Other (Income) Expense        
Interest income (216) (107) (600) (151)
Interest expense 213
Change in fair value of derivative liability (485) (58) (4,796) (81)
Gain on extinguishment of debt (547)
Unrealized (gain) loss on short term investments (5) 23 (43) 53
Total Other (Income) Expense (706) (142) (5,773) (179)
Net Loss $ (2,416) $ (6,881) $ (4,635) $ (15,300)
Net Loss Per Share - Basic $ (0.06) $ (0.22) $ (0.12) $ (0.48)
Net Loss Per Share - Diluted $ (0.06) $ (0.22) $ (0.12) $ (0.48)
Weighted average common shares outstanding - basic 41,016,075 31,380,634 40,095,945 31,723,792
Weighted average common shares outstanding - diluted 41,016,075 31,380,634 40,095,945 31,723,792